161 related articles for article (PubMed ID: 37186964)
1. Design and synthesis of N-acyl and dimeric N-Arylpiperazine derivatives as potential antileishmanial agents.
Ansari SB; Kamboj S; Ramalingam K; Meena R; Lal J; Kant R; Shukla SK; Goyal N; Reddy DN
Bioorg Chem; 2023 Aug; 137():106593. PubMed ID: 37186964
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of novel halogen rich salicylanilides as potential antileishmanial agents.
Lal J; Ramalingam K; Meena R; Ansari SB; Saxena D; Chopra S; Goyal N; Reddy DN
Eur J Med Chem; 2023 Jan; 246():114996. PubMed ID: 36565533
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and Antileishmanial Activity of 1,2,4,5-Tetraoxanes against
Cabral LIL; Pomel S; Cojean S; Amado PSM; Loiseau PM; Cristiano MLS
Molecules; 2020 Jan; 25(3):. PubMed ID: 31979089
[TBL] [Abstract][Full Text] [Related]
4. In vitro susceptibilities of Leishmania donovani promastigote and amastigote stages to antileishmanial reference drugs: practical relevance of stage-specific differences.
Vermeersch M; da Luz RI; Toté K; Timmermans JP; Cos P; Maes L
Antimicrob Agents Chemother; 2009 Sep; 53(9):3855-9. PubMed ID: 19546361
[TBL] [Abstract][Full Text] [Related]
5. Bio-guided isolation of anti-leishmanial natural products from Diospyros gracilescens L. (Ebenaceae).
Njanpa CAN; Wouamba SCN; Yamthe LRT; Dize D; Tchatat BMT; Tsouh PVF; Pouofo MN; Jouda JB; Ndjakou BL; Sewald N; Kouam SF; Boyom FF
BMC Complement Med Ther; 2021 Mar; 21(1):106. PubMed ID: 33789661
[TBL] [Abstract][Full Text] [Related]
6. Rationally Designed Minimal Bioactive Domains of AS-48 Bacteriocin Homologs Possess Potent Antileishmanial Properties.
Corman HN; Ross JN; Fields FR; Shoue DA; McDowell MA; Lee SW
Microbiol Spectr; 2022 Dec; 10(6):e0265822. PubMed ID: 36342284
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of new N-benzyl-1H-benzimidazol-2-amine derivatives against cutaneous, mucocutaneous and visceral Leishmania species.
Nieto-Meneses R; Castillo R; Hernández-Campos A; Maldonado-Rangel A; Matius-Ruiz JB; Trejo-Soto PJ; Nogueda-Torres B; Dea-Ayuela MA; Bolás-Fernández F; Méndez-Cuesta C; Yépez-Mulia L
Exp Parasitol; 2018 Jan; 184():82-89. PubMed ID: 29191699
[TBL] [Abstract][Full Text] [Related]
8. Triazino indole-quinoline hybrid: a novel approach to antileishmanial agents.
Sharma R; Pandey AK; Shivahare R; Srivastava K; Gupta S; Chauhan PM
Bioorg Med Chem Lett; 2014 Jan; 24(1):298-301. PubMed ID: 24314395
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and biological evaluation of quinoline-piperazine/pyrrolidine derivatives as possible antileishmanial agents.
Katiyar S; Ramalingam K; Kumar A; Ansari A; Bisen AC; Mishra G; Sanap SN; Bhatta RS; Purkait B; Goyal N; Sashidhara KV
Eur J Med Chem; 2023 Dec; 261():115863. PubMed ID: 37837672
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy of leishmaniasis. Part IX: synthesis and bioevaluation of aryl substituted ketene dithioacetals as antileishmanial agents.
Kumar S; Tiwari A; Suryawanshi SN; Mittal M; Vishwakarma P; Gupta S
Bioorg Med Chem Lett; 2012 Nov; 22(21):6728-30. PubMed ID: 23031588
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of ferrocenylquinoline as a potential antileishmanial agent.
Yousuf M; Mukherjee D; Pal A; Dey S; Mandal S; Pal C; Adhikari S
ChemMedChem; 2015 Mar; 10(3):546-54. PubMed ID: 25619822
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of novel triazolyl quinoline derivatives as potential antileishmanial agents.
Upadhyay A; Kushwaha P; Gupta S; Dodda RP; Ramalingam K; Kant R; Goyal N; Sashidhara KV
Eur J Med Chem; 2018 Jun; 154():172-181. PubMed ID: 29793211
[TBL] [Abstract][Full Text] [Related]
13. Development and evaluation of a cedrol-loaded nanostructured lipid carrier system for in vitro and in vivo susceptibilities of wild and drug resistant Leishmania donovani amastigotes.
Kar N; Chakraborty S; De AK; Ghosh S; Bera T
Eur J Pharm Sci; 2017 Jun; 104():196-211. PubMed ID: 28400285
[TBL] [Abstract][Full Text] [Related]
14. Cynaroside inhibits Leishmania donovani UDP-galactopyranose mutase and induces reactive oxygen species to exert antileishmanial response.
Tabrez S; Rahman F; Ali R; Alouffi AS; Akand SK; Alshehri BM; Alshammari FA; Alam A; Alaidarous MA; Banawas S; Dukhyil AAB; Rub A
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33367614
[TBL] [Abstract][Full Text] [Related]
15. In vitro antileishmanial activity of thioridazine on amphotericin B unresponsive/ sensitive Leishmania donovani promastigotes and intracellular amastigotes.
Kumar V; Kumari S; Ranjan R; Kumar A; Alti D
Exp Parasitol; 2024 Feb; 257():108688. PubMed ID: 38142765
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological evaluation of aryl pyrimidine derivatives as potential leishmanicidal agents.
Suryawanshi SN; Kumar S; Shivahare R; Pandey S; Tiwari A; Gupta S
Bioorg Med Chem Lett; 2013 Sep; 23(18):5235-8. PubMed ID: 23910597
[TBL] [Abstract][Full Text] [Related]
17. Antileishmanial ferrocenylquinoline derivatives: Synthesis and biological evaluation against Leishmania donovani.
Yousuf M; Mukherjee D; Dey S; Pal C; Adhikari S
Eur J Med Chem; 2016 Nov; 124():468-479. PubMed ID: 27598235
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, in vitro and in vivo biological evaluation of pyranone-piperazine analogs as potent antileishmanial agents.
Mishra S; Parmar N; Chandrakar P; Sharma CP; Parveen S; Vats RP; Seth A; Goel A; Kar S
Eur J Med Chem; 2021 Oct; 221():113516. PubMed ID: 33992928
[TBL] [Abstract][Full Text] [Related]
19. Eugenol derived immunomodulatory molecules against visceral leishmaniasis.
Charan Raja MR; Velappan AB; Chellappan D; Debnath J; Kar Mahapatra S
Eur J Med Chem; 2017 Oct; 139():503-518. PubMed ID: 28826085
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and in vitro antileishmanial efficacy of novel quinazolinone derivatives.
Prinsloo IF; Zuma NH; Aucamp J; N'Da DD
Chem Biol Drug Des; 2021 Feb; 97(2):383-398. PubMed ID: 32914553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
